| Impact of delay in follow‐up due to COVID‐19 pandemic on skin cancer progression: a real‐life experience from an Italian hub hospital M Valenti, G Pavia, L Gargiulo, P Facheris, O Nucca, L Mancini, F Sacrini, ... International journal of dermatology 60 (7), 860-863, 2021 | 41 | 2021 |
| Real-life effectiveness and safety of risankizumab in 131 patients affected by moderate-to-severe plaque psoriasis: a 52-week retrospective study L Gargiulo, L Ibba, G Pavia, CA Vignoli, F Piscazzi, M Valenti, F Sanna, ... Dermatology and Therapy 12 (10), 2309-2324, 2022 | 26 | 2022 |
| Real-life effectiveness and safety of risankizumab in moderate-to-severe plaque psoriasis: a 40-week multicentric retrospective study RG Borroni, P Malagoli, L Gargiulo, M Valenti, G Pavia, P Facheris, ... Acta Dermato-Venereologica 101 (11), 2021 | 26 | 2021 |
| Anti‐IL17 and anti‐IL23 biologic drugs for scalp psoriasis: a single‐center retrospective comparative study A Narcisi, M Valenti, A Cortese, F Toso, G Pavia, L Gargiulo, R Borroni, ... Dermatologic Therapy 35 (2), e15228, 2022 | 25 | 2022 |
| Non‐complicated evolution of COVID‐19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab M Valenti, P Facheris, G Pavia, L Gargiulo, RG Borroni, A Costanzo, ... Dermatologic Therapy 33 (4), 2020 | 25 | 2020 |
| Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: a 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) A Narcisi, M Valenti, L Gargiulo, L Ibba, F Amoruso, G Argenziano, ... Journal of the European Academy of Dermatology and Venereology 37 (1), 93-103, 2023 | 23 | 2023 |
| A fatal case of COVID‐19 infection presenting with an erythema multiforme‐like eruption and fever L Gargiulo, G Pavia, P Facheris, M Valenti, F Sacrini, A Narcisi, R Borroni, ... Dermatologic Therapy 33 (4), 2020 | 23 | 2020 |
| Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID‐19 vaccine, successfully treated with risankizumab G Pavia, L Gargiulo, F Spinelli, J Avagliano, M Valenti, RG Borroni, ... Journal of the European Academy of Dermatology and Venereology 36 (7), e502, 2022 | 22 | 2022 |
| Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single-center real-life population M Valenti, G Pavia, L Gargiulo, P Facheris, F Sanna, RG Borroni, ... Journal of Dermatological Treatment 33 (3), 1638-1642, 2022 | 22 | 2022 |
| Real‐life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: a 104‐week multicenter retrospective study–IL PSO … L Gargiulo, L Ibba, P Malagoli, RG Angileri, F Bardazzi, N Bernardini, ... Journal of the European Academy of Dermatology and Venereology 37 (5), 1017-1027, 2023 | 21 | 2023 |
| Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis) L Gargiulo, A Narcisi, L Ibba, A Balato, L Bianchi, P Brianti, D Buononato, ... Frontiers in Medicine 10, 1243843, 2023 | 20 | 2023 |
| Real-life effectiveness and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: a single-center 16-week study L Gargiulo, L Ibba, A Cortese, J Avagliano, M Valenti, A Costanzo, ... Dermatology and Therapy 13 (2), 651-660, 2023 | 18 | 2023 |
| Safety of biologic therapies in patients with moderate-to-severe plaque psoriasis and concomitant viral hepatitis: a monocentric retrospective study L Gargiulo, G Pavia, M Valenti, A Lleo de Nalda, C Perugini, A Costanzo, ... Dermatology and Therapy 12 (5), 1263-1270, 2022 | 18 | 2022 |
| What can IBD specialists learn from IL-23 trials in dermatology? M Valenti, A Narcisi, G Pavia, L Gargiulo, A Costanzo Journal of Crohn's and Colitis 16 (Supplement_2), ii20-ii29, 2022 | 13 | 2022 |
| Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series L Gargiulo, L Ibba, G Pavia, J Avagliano, A Cortese, A Costanzo, A Narcisi Journal of Dermatological Treatment 34 (1), 2183729, 2023 | 12 | 2023 |
| New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series L Gargiulo, L Ibba, CA Vignoli, F Piscazzi, A Cortese, G Fiorillo, F Toso, ... Journal of Dermatological treatment 34 (1), 2023 | 11 | 2023 |
| Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis) L Gargiulo, L Ibba, P Malagoli, F Amoruso, G Argenziano, A Balato, ... Frontiers in Medicine 10, 2023 | 11 | 2023 |
| Sub‐erythrodermic psoriasis successfully treated with bimekizumab: A case report M Valenti, L Gargiulo, L Ibba, G Pavia, A Narcisi, A Costanzo Dermatologic Therapy 35 (12), 2022 | 11 | 2022 |
| Complicated coronavirus disease 2019 (COVID‐19) in a psoriatic patient treated with ixekizumab. P Facheris, M Valenti, G Pavia, L Gargiulo, A Narcisi, A Costanzo, ... International Journal of Dermatology 59 (8), 2020 | 11 | 2020 |
| Effectiveness and safety of upadacitinib for moderate-to-severe atopic dermatitis in a real-world setting: A 52-week retrospective study L Gargiulo, L Ibba, F Piscazzi, A Alfano, RC Ingurgio, M Valenti, ... Journal of the European Academy of Dermatology and Venereology: JEADV 38 (2 …, 2024 | 10 | 2024 |
Luciano IbbaHumanitas UniversityVerified email at humanitas.it
